Cargando…
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Doxorubicin (DOX) is an anthracycline antibiotic frequently used against a wide range of cancers, including breast cancer. Although the drug is effective as a treatment against cancer, many patients develop heart failure (HF) months to years following their last treatment with DOX. The challenge in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434835/ https://www.ncbi.nlm.nih.gov/pubmed/36050733 http://dx.doi.org/10.1186/s12944-022-01694-y |